Trial
NCT04526288
CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
Jazz Pharmaceuticals
Condition
Acute Myeloid Leukemia
Intervention
Allogeneic Hematopoietic Stem Cell Transplantation
Why stopped
Terminated due to low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-23